Published: 2019-10-14 03:15:37
SUMMARY
More
than 25 million Americans have asthma. This includes 7.7 percent of adults
and 8.4 percent of children according to 2018 data from the U.S. Centers
for Disease Control and Prevention. Dr. Kraft is an internationally
renowned physician-scientist who specializes in translational asthma
research. She focuses her work on precision medicine therapies to treat
severe asthma. Her research has been funded by the National Institutes of
Health (NIH) and the American Lung Association for nearly 25 years. As a
principal investigator, she currently is in the third year of a 5-year,
$7.02 million grant from the National Institute of Allergy and Infectious
Diseases, an NIH unit, to study “Dysfunction of Innate Immunity in
Asthma,” and in the first year of a 6-year, $2.42 million grant from the
National Heart, Lung, and Blood Institute, another NIH unit, for
participation in the PrecISE Network, a national research network that
evaluates precision medicine approaches for the treatment of severe
asthma. She also is principal investigator on an Arizona Biomedical
Research Commission grant and co-principal investigator with Lynn Gerald,
PhD, MSPH, as the UA is a site for the American Lung Association Clinical
Research Centers to evaluate new treatments for asthma and chronic
obstructive pulmonary disease (COPD).
https://www.azbio.org/monica-kraft-md-of-the-university-of-arizona-named-arizona-bioscience-researcher-for-the-year